Success Stories: From Behavioral Science to Public Health Equity—How One Researcher Is Advancing Vaccine Confidence and Global Health
Client’s Testimonial:
“Overall, the case preparation process went very smoothly. My questions were answered promptly and clearly…Thank you for your help throughout the process.”
On May 15th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Contractor working in the Field of Behavioral Sciences (Approval Notice).
General Field: Behavioral Sciences
Position at the Time of Case Filing: Contractor
Country of Origin: Japan
Country of Residence at the Time of Filing: Japan
Approval Notice Date: May 15th, 2025
Processing Time: 11 months, 2 days
Case Summary:
For this researcher from Japan, behavioral science isn’t just a field of study—it’s a bridge to better health outcomes, more informed communities, and smarter, more equitable health systems. His recent NIW approval recognizes his vital role in promoting vaccine confidence, managing public health misinformation, and shaping responsible use of AI in health communication—critical needs in today’s rapidly evolving global health landscape.
The Mission: Empower Communities Through Evidence-Based Interventions
His work lies at the intersection of behavioral science, global health policy, and community engagement. Through his position at a prominent global health nonprofit, he designs and evaluates strategies that improve immunization uptake, build trust in vaccines, and combat misinformation. He also contributes to pandemic preparedness initiatives.
His focus on understanding social drivers of health, such as inequality, education, and cultural context, has direct applications to several U.S. priorities, including addressing health disparities, reducing preventable disease, and building resilient public health infrastructure.
An Evidence-Based Career
His case was rooted in a robust record of scholarly output and influence. At the time of filing, he had authored 16 peer-reviewed journal articles, 8 conference abstracts, 1 book chapter, and 1 technical report. His work has been cited over 769 times, with multiple papers ranking in the top 0.1% to 10% most cited in their fields.
Examples of his most impactful research include:
● A Lancet Public Health paper exploring health communication strategies for pandemic response.
● A publication in Vaccine on social and behavioral drivers of immunization.
Influencing the Field—Globally
The strength of his petition came not just from the volume of his work, but its reach and impact. His research has been cited by scientists and public health leaders working on:
● COVID-19 vaccine uptake across low- and middle-income countries
● Ethical frameworks for AI in public health campaigns
● Strategies to counter vaccine misinformation on social media
● Cross-cultural health communication methods
Backed by Institutions—and Impact
He has served as a peer reviewer for at least 2 major journals in the fields of public health, social science, and global medicine, including PLOS ONE and Human Vaccines & Immunotherapeutics. His work has received institutional support from the government and international organizations.
His future plans involve continuing his research in the U.S., with a focus on socio-behavioral assessments and policy-level intervention design. His long-term goal is to partner with public agencies and global institutions to strengthen evidence-based public health infrastructure.
Why This Petition Worked
His EB-2 NIW petition was approved because of his work:
● Holds substantial merit, addressing public health misinformation, vaccine equity, and AI ethics
● Bears national importance through its implications for pandemic preparedness and public trust
● Is led by a researcher with proven academic and professional success
● Would benefit the U.S. even without labor certification, given his unique contributions to urgent health challenges
This success reflects what we believe at our core: that immigration is a force for good when it supports individuals making a measurable impact on society. This client’s story is one of purpose, evidence, and vision—and now, thanks to his NIW approval, it’s also a story with a future in the United States.

